Business Description
Euro-Med Laboratories Philippines Inc
ISIN : PHY2352T1098
Total Employee Number:
1,200Compare
Compare
Traded in other countries / regions
EURO.Philippines IPO Date
1998-07-02Description
Euro-Med Laboratories Philippines Inc is a pharmaceutical-based company that engages in the manufacture of pharmaceutical products such as large and small-volume parenterals and other solutions. The company also manufactures sterile water for injection, and other solutions such as ophthalmic, inhalation, irrigation, and dialysis. The Company also manufactures intravenous fluids in glass bottles, hemodialysis concentrates, ophthalmic products and disinfectants.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.41 | |||||
Equity-to-Asset | 0.55 | |||||
Debt-to-Equity | 0.68 | |||||
Debt-to-EBITDA | 3.13 | |||||
Interest Coverage | 2.97 | |||||
Piotroski F-Score | 8/9 | |||||
Altman Z-Score | 1.9 | |||||
Beneish M-Score | -2.74 | |||||
WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 17.6 | |||||
3-Year EBITDA Growth Rate | 19.9 | |||||
3-Year EPS without NRI Growth Rate | 26.8 | |||||
3-Year FCF Growth Rate | 129.8 | |||||
3-Year Book Growth Rate | 2.1 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 65.77 | |||||
9-Day RSI | 60.12 | |||||
14-Day RSI | 56.69 | |||||
3-1 Month Momentum % | 6 | |||||
6-1 Month Momentum % | 4.95 | |||||
12-1 Month Momentum % | 23.26 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.49 | |||||
Quick Ratio | 1.1 | |||||
Cash Ratio | 0.45 | |||||
Days Inventory | 137.12 | |||||
Days Sales Outstanding | 101.86 | |||||
Days Payable | 28.3 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 6.36 | |||||
Dividend Payout Ratio | 0.64 | |||||
3-Year Dividend Growth Rate | 51.8 | |||||
Forward Dividend Yield % | 6.36 | |||||
5-Year Yield-on-Cost % | 15.89 | |||||
Shareholder Yield % | 6.88 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 36.47 | |||||
Operating Margin % | 13.06 | |||||
Net Margin % | 7.12 | |||||
EBITDA Margin % | 19.39 | |||||
FCF Margin % | 12.2 | |||||
OCF Margin % | 15.8 | |||||
ROE % | 8.01 | |||||
ROA % | 4.42 | |||||
ROIC % | 7.15 | |||||
3-Year ROIIC % | 91 | |||||
ROC (Joel Greenblatt) % | 11.27 | |||||
ROCE % | 13.05 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 10 | |||||
PE Ratio without NRI | 10 | |||||
Shiller PE Ratio | 12.82 | |||||
Price-to-Owner-Earnings | 5.47 | |||||
PEG Ratio | 0.81 | |||||
PS Ratio | 0.69 | |||||
PB Ratio | 0.74 | |||||
Price-to-Tangible-Book | 0.77 | |||||
Price-to-Free-Cash-Flow | 5.5 | |||||
Price-to-Operating-Cash-Flow | 4.28 | |||||
EV-to-EBIT | 7.36 | |||||
EV-to-EBITDA | 5.26 | |||||
EV-to-Revenue | 1.02 | |||||
EV-to-FCF | 8.35 | |||||
Price-to-GF-Value | 1.08 | |||||
Price-to-Projected-FCF | 0.55 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.67 | |||||
Price-to-Graham-Number | 0.59 | |||||
| Price-to-Net-Current-Asset-Value | 7.33 | |||||
Earnings Yield (Greenblatt) % | 13.59 | |||||
FCF Yield % | 18.46 | |||||
Forward Rate of Return (Yacktman) % | 20.55 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Euro-Med Laboratories Philippines Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₱) | 6,841.218 | ||
| EPS (TTM) (₱) | 0.11 | ||
| Beta | 0.719 | ||
| 3-Year Sharpe Ratio | 0.46 | ||
| 3-Year Sortino Ratio | 0.83 | ||
| Volatility % | 23.5 | ||
| 14-Day RSI | 56.69 | ||
| 14-Day ATR (₱) | 0.018711 | ||
| 20-Day SMA (₱) | 1.071 | ||
| 12-1 Month Momentum % | 23.26 | ||
| 52-Week Range (₱) | 0.72 - 1.31 | ||
| Shares Outstanding (Mil) | 4,112.14 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Euro-Med Laboratories Philippines Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Euro-Med Laboratories Philippines Inc Stock Events
| Event | Date | Price (₱) | ||
|---|---|---|---|---|
| PHP 0.070000 Cash Dividend | 2025-11-13 | 1.10 (+0.00%) | ||
| PHP 0.060000 Cash Dividend | 2024-11-14 | 0.90 (+1.12%) | ||
| 1.07:1 Stock Split | 2011-07-05 | 1.68 (+0.00%) | ||
| 1.08467:1 Stock Split | 2010-10-12 | 1.50 (+0.00%) | ||
| 1.1:1 Stock Split | 2009-06-30 | 1.33 (-2.30%) | ||
| 1.1:1 Stock Split | 2008-07-01 | 1.42 (+0.00%) | ||
| 1.1:1 Stock Split | 2007-06-29 | 1.36 (+0.00%) | ||
| 1.1:1 Stock Split | 2004-06-02 | -- | ||
| 1.15942:1 Stock Split | 2003-06-02 | -- | ||
| 1.15:1 Stock Split | 2002-07-05 | -- |
Show
Entries
Euro-Med Laboratories Philippines Inc Frequently Asked Questions
What is Euro-Med Laboratories Philippines Inc(PHS:EURO)'s stock price today?
The current price of PHS:EURO is ₱1.10. The 52 week high of PHS:EURO is ₱1.31 and 52 week low is ₱0.72.
When is next earnings date of Euro-Med Laboratories Philippines Inc(PHS:EURO)?
The next earnings date of Euro-Med Laboratories Philippines Inc(PHS:EURO) is .
Does Euro-Med Laboratories Philippines Inc(PHS:EURO) pay dividends? If so, how much?
The Dividend Yield %  of Euro-Med Laboratories Philippines Inc(PHS:EURO) is 6.36% (As of Today), Highest Dividend Payout Ratio of Euro-Med Laboratories Philippines Inc(PHS:EURO) was 1.02. The lowest was 0.4. And the median was 0.66. The  Forward Dividend Yield % of Euro-Med Laboratories Philippines Inc(PHS:EURO) is 6.36%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Euro-Med Laboratories Philippines Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers